Verlag des Forschungszentrums Jülich

JUEL-3499
Ermert, Johannes
Zur trägerarmen Markierung von Arylalkylaminen mit n.c.a. (18F)Fluorid am Beispiel von Norephedrin und Metaraminol
136 S., 1998



A new pathway for the no carrier added (n.c.a.) 18F-labelling of biogenic arylalkylamines such as [18F]fluoronorephedrine and [18F]fluorometaraminol (FMR) via nucleophilic aromatic substitution was developed. To overcome the problem of low specific activity, not to avoid with previous electrophilic fluorination, 18F-labelled arylalkylamines were synthesized by direct nucleophilic exchange with n.c.a. [18F]fluoride starting with a keto-activated aromatic system and consecutive chiral reduction of the keto-function.

With regard to a stereoselective reduction of the carbonyl group, several N-protected -aminopropiophenones were prepared as model compounds in order to examine the influence of the protecting group on the radiochemical yield of a 18F-for-X substitution (X= F, Cl, NO2, +N(CH3)3).

Good radiochemical yields could be achieved using the N-dibenzyl- or acetyl-protected compounds. The para-position of the leaving group provided higher radiochemical yields than the ortho-position in the case of the 18F-for-19F substitution. It has been shown that the less basic oxalate/cryptate system does not increase the radiochemical yields.

18F-Fluorination of the nitro compound failed because the precursor was not stable under labelling conditions. The best results of n.c.a. 18F-fluorination were obtained using the trimethylammonium leaving group (X = +N(CH3)3) in para-position (RCY about 50 %), however, a selective quaternisation of the dimethylaniline group was only possible when using the N,N-dibenzylated derivative.

The n.c.a. labelling of 4-[18F]fluoronorephedrine and 4-[18F]fluorometaraminol was finally performed via 18F-for-N(CH3)3 substitution on 4-(2-N,N- dibenzylaminopropionyl)phenyl-1-N,N,N-trimethyl- ammonium triflate and 4-(2-N,N-dibenzylaminopropionyl)-2-benzyloxyphenyl-1-N,N,N-trimethyl- ammonium triflate, respectively. The precursor of 4-[18F]fluorometaraminol has been synthesized in an eleven step reaction sequence and characterized with IR and 1H-NMR.

The formation of the threo-isomer of n.c.a. 4-[18F]fluoronorephedrine was achieved by reduction of n.c.a. 2-N,N-dibenzylamino-1-(4-[18F]fluorophenyl)propan-1-on using sodium borohydride in methanol as reducing agent. The radiochemical yield was about 20% after hydrogenolytical debenzylation using ammonium formate and palladium on charcoal.

The formation of the erythro-isomer of 4-[18F]fluoronorephedrine and 4- [18F]fluorometaraminol was accomplished with BH3 THF in the presence of 2-N,N-dibenzylamino-1-(4- [18F]fluoro- phenyl)propan-1-on and 2-N,N-dibenzylamino-1-(4-[18F]fluoro-3-benzyloxyphenyl)propan-1-on respectively. The ratio of erythro- to threo-isomer was 4:1. The radiochemical yield of erythro-4- [18F]fluoronorephedrine and erythro-4-[18F]fluorometaraminol after deprotection using ammonium formate and palladium on charcoal was 15-20 ;#37; with a specific activity of about 74 GBq/[my]mol (2 Ci/[my]mol).

The new synthetic pathway makes it possible to synthesize these labelled sympathomimetics no carrier added and to investigate the presynaptic adrenergic nervous system of the heart using positron emission tomography.


Neuerscheinungen

Schriften des Forschungszentrums Jülich

Ihre Ansprechperson

Heike Lexis
+49 2461 61-5367
zb-publikation@fz-juelich.de

Letzte Änderung: 07.06.2022